check quantity

RediJect 2-DG Fluorescent Imaging Probe (Standard kit)

XenoLight RediJect 2-DeoxyGlucosone (DG) 750 is a fluorescent imaging probe for in vivo targeting of tumors that typically exhibit elevated glucose uptake rate in comparison to surrounding tissues. To achieve maximum glucose targeting and enhanced tumor uptake, the probe has been designed to contain four 2-DG molecules per dye molecule.  

Please enter valid quantity

Please login to add favorites

NULL OR EMPTY CART

Product Number List Price Your Price Quantity
760562 453.00 USD

You successfully added item(s) to your cart

Overview

RediJect 2-DG fluorescent imaging probe Standard Kit:

  • Novel ready-to-use probe to monitor glucose uptake in vivo non-invasively
  • Dispensed to image 20 animals
  • Maximum glucose targeting and enhanced tumor uptake
  • In vivo imaging quality, validated on IVIS imaging systems

For laboratory use only. This product is intended for animal research only and not for use in humans.

Disclaimer: For laboratory use only. This product is intended for animal research only and not for use in humans.

Specifications

Fluorescent Agent Type Targeted
Optical Imaging Classification Fluorescence Imaging
Product Brand Name XenoLight
Shipping Condition Blue Ice
Therapeutic Area Oncology/Cancer, Arthritis, Inflammation
Unit Size 1 Kit (20 animals)
Wave Length 750 nm

Resources, Events & More

Resource Type File Name File Format
Brochure In Vivo Imaging Agents Brochure PDF 2 MB
Brochure XenoLight RediJect 2-DG-750 Probe (Product Sheet) PDF 985 KB
Data Sheet Material Safety Data Sheet PDF 100 KB
Citations Library View peer reviewed publications using PerkinElmer's In Vivo Imaging Reagents Link